Please sign in to follow a disease.
Superficial multifocal basal cell carcinoma
MONDO:0002954A superficial basal cell carcinoma of the skin characterized by the presence of lobules of basaloid cells which are separated by large distances and represent multifocal discrete tumors.
Also known as: multicentric basal cell carcinoma, multifocal superficial basal cell carcinoma, multifocal superficial basal cell carcinoma (morphologic abnormality), superficial multifocal basal cell carcinoma, superficial basal cell carcinoma
2780 clinical trials for this condition and its sub-types, 7 tagged with Superficial multifocal basal cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Major trial may spare thousands of breast cancer patients from chemo
Disease control OngoingThis large phase 3 trial studied over 5,000 women with hormone receptor-positive, HER2-negative breast cancer that had spread to 1-3 lymph nodes. Participants received standard hormone therapy (tamoxifen or an aromatase inhibitor) either alone or with chemotherapy. The goal was t…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Laser guided by High-Tech camera could zap skin cancer with less scarring
Disease control OngoingThis study tests whether a laser, guided by a special camera (OCT), can effectively treat basal cell carcinoma, a common skin cancer. About 40 adults with confirmed BCC will receive the laser treatment. The goal is to see if the cancer is completely removed, potentially offering …
Sponsor: Christopher Zachary • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New light therapy could zap skin cancer without surgery
Disease control OngoingThis Phase 3 trial tests whether a gel called Ameluz® combined with a special red light can effectively treat superficial basal cell carcinoma, a common skin cancer. About 187 adults with at least one lesion are enrolled. The main goal is to see if the treated skin cancer clears …
Phase 3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC